Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the performance of the EnLightTM and LightPathTM Imaging Systems in
detecting tumour lesions in patients with gastric, pancreas, bile duct or duodenal cancer.
EnLightTM will be used to detect positron emission and the LightPathTM system to detect
Cerenkov Luminescence. Both are emitted by the Positron Emission Tomography (PET) agent.
The study will also evaluate the patient safety and radiation safety of the EnLightTM, and
the safety for the device operators and surgical staff of the LightPathTM Imaging System.